OverviewSuggest Edit

Alteogen is a biopharmaceutical company that develops therapeutic proteins, antibody-drug conjugates, (ADCs), and monoclonal antibody biosimilars. It provides NexP fusion technology that supports the production of Human Growth Hormone (HGH), long-acting exenatide (for diabetes), and long-acting Factor VIIa (for hemophilia).
TypePublic
Founded2008
Websitealteogen.com

Latest Updates

Share Price (Jun 2021)₩69.9 K
Cybersecurity ratingCMore

Alteogen Financials and Metrics

Alteogen Revenue

Market capitalization (4-Jun-2021)

949.1b

Closing stock price (4-Jun-2021)

69.9k
Alteogen's current market capitalization is ₩949.1 b.
Show all financial metrics

Alteogen Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

Alteogen Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Alteogen Online and Social Media Presence

Embed Graph

Alteogen Frequently Asked Questions

  • When was Alteogen founded?

    Alteogen was founded in 2008.

  • Who are Alteogen competitors?

    Competitors of Alteogen include Abarceo Pharma, Amarillo Biosciences and WinSanTor.